MROPF (MicroPort CardioFlow Medtech) Beginning Cash Position: $46.26 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MROPF MicroPort CardioFlow Medtech Corp MROPF
59 GF Score
Price $0.65
GF Value $3.23
! 11 Warning Signs
View Full Analysis

What is MicroPort CardioFlow Medtech Beginning Cash Position?

MicroPort CardioFlow Medtech MROPF 59 Beginning Cash Position is $46.26 Mil as of Dec. 2025. GuruFocus rates MROPF with a GF Score™ of 59/100 and a GF Value™ of $3.23. The stock has 11 warning signs investors should review.

MicroPort CardioFlow Medtech's Beginning Cash Position for the quarter that ended in Dec. 2025 was $46.26 Mil.

MicroPort CardioFlow Medtech's quarterly Beginning Cash Position declined from Dec. 2024 ($114.06 Mil) to Jun. 2025 ($15.06 Mil) but then increased from Jun. 2025 ($15.06 Mil) to Dec. 2025 ($46.26 Mil).

MicroPort CardioFlow Medtech's annual Beginning Cash Position declined from Dec. 2023 ($263.29 Mil) to Dec. 2024 ($150.38 Mil) and declined from Dec. 2024 ($150.38 Mil) to Dec. 2025 ($15.03 Mil).

MicroPort CardioFlow Medtech Beginning Cash Position Related Terms

MicroPort CardioFlow Medtech Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for MicroPort CardioFlow Medtech's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MicroPort CardioFlow Medtech Beginning Cash Position Chart

MicroPort CardioFlow Medtech Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial 96.09 320.55 263.29 150.38 15.03

MicroPort CardioFlow Medtech Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 151.11 146.54 114.06 15.06 46.26
MROPF
59GF Score
MicroPort CardioFlow Medtech Corp MROPF
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MicroPort CardioFlow Medtech Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $46.26 Mil mean?
MicroPort CardioFlow Medtech (MROPF) has a Beginning Cash Position of $46.26 Mil as of Dec. 2025. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on MicroPort CardioFlow Medtech and its competitors.
Is MicroPort CardioFlow Medtech's Beginning Cash Position too high?
MicroPort CardioFlow Medtech's current Beginning Cash Position is $46.26 Mil. Overall, MicroPort CardioFlow Medtech has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does MicroPort CardioFlow Medtech's Beginning Cash Position compare to ABT and SYK?
MicroPort CardioFlow Medtech's Beginning Cash Position of $46.26 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Devices & Instruments company?
A good Beginning Cash Position depends on the Medical Devices & Instruments industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on MicroPort CardioFlow Medtech and its competitors. MicroPort CardioFlow Medtech's current Beginning Cash Position is $46.26 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MicroPort CardioFlow Medtech stock overvalued right now?
MicroPort CardioFlow Medtech (MROPF) has a current Beginning Cash Position of $46.26 Mil. The stock's GF Value™ is $3.23, compared to a current price of $0.65 — trading 80% below its estimated fair value. The current Beginning Cash Position is $46.26 Mil. MicroPort CardioFlow Medtech's overall GF Score™ is 59/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For MicroPort CardioFlow Medtech (MROPF), the current Beginning Cash Position is $46.26 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MicroPort CardioFlow Medtech (MROPF) Overvalued in 2026?

Based on GuruFocus' analysis, MicroPort CardioFlow Medtech stock appears to be undervalued. The current stock price of $0.65 is trading 80% below its estimated GF Value™ of $3.23.

Key valuation signals for MROPF:

  • Beginning Cash Position: $46.26 Mil
  • GF Value™: $3.23 vs. price of $0.65 (80% below fair value)
  • GF Score™: 59/100 with 11 warning signs

No single metric tells the full story. See the MROPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MicroPort CardioFlow Medtech Business Description

Other Exchanges 02160:Hong Kong72X0:Germany
Address No. 501 Niudun Road, Zhangjiang Hi-Tech Park, Pudong New District, Shanghai, CHN, 201203
MicroPort CardioFlow Medtech Corp is a medical device company in China focusing on the research, development, and commercialization of transcatheter and surgical solutions for valvular heart diseases. The company's product portfolio consists of VitaFlow, VitaFlow Liberty, Angelguide and AnchorMan. The Group derives revenue from the sales of medical devices through appointed distributors. It derives maximum revenue from PRC.
59GF Score

Get the complete analysis for MROPF

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.65
Price
$3.23
GF Value